Jupiter Life Lin Q3 FY26 Earnings Analysis

- Jupiter Life Line Hospitals anticipates strong long-term demand growth, especially in new markets like Dombivali, due to lack of supply and dense population. - ARPOB (Average Revenue Per Occupied Bed) improved ~15% in H1 FY26 driven by case mix optimization and rate revisions. - New hospitals (Dombivali, South Pune, Mira Road) are under development, expected to augment future revenue streams. - Dombivali Hospital is expected to start operations by Q1 FY27; initial years may see lower ARPOB and occupancy, with break-even likely by year two at ~40-45% occupancy. - Existing hospitals show steady or increasing occupancy (e.g., Thane plateaued mid-70%, Pune approaching 70%, Indore rising after bed additions). - Overall volume growth is stable, with IP volumes flat year-on-year in 1H FY26. - Future growth to be driven by organic expansion, operational efficiency, and potential inorganic opportunities in Western India.

- Mature hospitals are expected to maintain EBITDA margins in the mid-20% range. - New hospitals like Dombivali are anticipated to be EBITDA negative in the first year and break even by the second year, potentially causing a short-term margin dilution. - Operating revenue growth was 11.7% YoY in Q2 FY26; H1 FY26 total operating income grew 14.9% YoY. - ARPOB (Average Revenue Per Occupied Bed) improved by nearly 15% in H1 FY26 due to case mix optimization and periodic rate revisions. - Occupancy across existing hospitals is stable to improving, with new hospitals expected to ramp up to around 40-45% occupancy by year two. - The company expects continued organic growth through expansion of bed capacity and geographic footprint in Western India. - No concrete inorganic acquisition plans yet, but the company remains open to sensible opportunities in Maharashtra, Gujarat, and Madhya Pradesh. - Overall, steady growth in earnings and profits is expected, with temporary margin moderation during new hospital ramp-ups.

- Current CAPEX incurred in H1 FY26 is approximately Rs. 110 crores, primarily for new projects. - Three key projects underway: Dombivali Hospital (on track to start Q1 next financial year), South Pune Hospital (construction started in Q3 FY26), and Mira Road Hospital (currently at architectural drawing stage). - The company's strategy involves completing these projects using internal accruals and existing resources without requiring significant additional debt. - No live inorganic acquisition deals in progress, but the company remains open to sensible opportunities in Western India, including Maharashtra, Gujarat, and Madhya Pradesh. - Debt currently stands at Rs. 325 crores, with liquid investments of Rs. 500-550 crores helping fund projects. - Future debt may increase only if a new project opportunity arises beyond these three ongoing developments.

- Currently, there is no live inorganic acquisition or fundraising activity underway. - Existing consolidated debt stands at Rs. 325 crores, with liquid investments of about Rs. 550 crores. - The company expects to complete ongoing projects (Dombivali, South Pune, Mira Road) using internal accruals and resources without additional debt. - New debt may be considered only if an additional project opportunity arises. - No specific mention of future equity fundraising in the transcript. - The management remains open to sensible opportunities in Western India but has nothing concrete on inorganic expansion or new fundraising at present.

- There is no explicit mention of a current or expected order book or pending orders for Jupiter Life Line Hospitals Limited in the provided transcript. - The company is focused on organic growth with ongoing discussions for new hospital projects but no concrete land acquisition or expansion plans are finalized yet (Page 11). - Three hospital projects are underway: Dombivali (near completion, expected operational in Q1 next financial year), South Pune (construction commenced in Q3 FY26), and Mira Road (architectural planning stage) (Page 3). - There is no live inorganic acquisition or expansion plans currently being chased, but the company is open to opportunities in Western India including Maharashtra, Gujarat, and Madhya Pradesh (Page 5). - No formal order book or pending project contracts are mentioned in the transcript.